RegenxBio proposes IPO

RegenxBio Inc., Washington, D.C. Business: Gene/Cell therapy Date announced: 2015-08-17 Type: IPO To be raised: Up to $100 million Shares: TBD Price: TBD Underwriters: Morgan Stanley; BofA Merrill Lyn...